James L. Weemhoff

919 total citations
24 papers, 709 citations indexed

About

James L. Weemhoff is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, James L. Weemhoff has authored 24 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in James L. Weemhoff's work include Drug-Induced Hepatotoxicity and Protection (10 papers), Drug Transport and Resistance Mechanisms (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). James L. Weemhoff is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (10 papers), Drug Transport and Resistance Mechanisms (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). James L. Weemhoff collaborates with scholars based in United States, Brazil and United Kingdom. James L. Weemhoff's co-authors include Hartmut Jaeschke, David J. Greenblatt, Lisa L. von Moltke, Jerold S. Harmatz, Kuo Du, Anup Ramachandran, Erdal Bedi̇r, Peter Goldman, Ikhlas A. Khan and Santosh Kumar and has published in prestigious journals such as The FASEB Journal, Journal of Hepatology and Food and Chemical Toxicology.

In The Last Decade

James L. Weemhoff

24 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James L. Weemhoff United States 16 287 224 126 101 97 24 709
Eduardo Fernández‐Martínez Mexico 17 152 0.5× 141 0.6× 76 0.6× 45 0.4× 141 1.5× 50 691
M. R. Slaughter United Kingdom 5 266 0.9× 203 0.9× 91 0.7× 77 0.8× 78 0.8× 9 702
Hamid Amouzadeh United States 13 433 1.5× 173 0.8× 193 1.5× 161 1.6× 87 0.9× 31 939
G Pisani Argentina 16 85 0.3× 242 1.1× 105 0.8× 90 0.9× 164 1.7× 41 749
Juhui Zhao China 9 130 0.5× 181 0.8× 106 0.8× 23 0.2× 159 1.6× 18 630
Ka Wu China 17 184 0.6× 290 1.3× 25 0.2× 52 0.5× 81 0.8× 28 766
Michael Atef Fawzy Egypt 14 106 0.4× 197 0.9× 51 0.4× 63 0.6× 80 0.8× 42 566
Guangyao Zhou China 15 90 0.3× 251 1.1× 137 1.1× 39 0.4× 229 2.4× 38 730
Marı́a Teresa Ronco Argentina 17 81 0.3× 256 1.1× 110 0.9× 77 0.8× 232 2.4× 37 770

Countries citing papers authored by James L. Weemhoff

Since Specialization
Citations

This map shows the geographic impact of James L. Weemhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James L. Weemhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James L. Weemhoff more than expected).

Fields of papers citing papers by James L. Weemhoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James L. Weemhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James L. Weemhoff. The network helps show where James L. Weemhoff may publish in the future.

Co-authorship network of co-authors of James L. Weemhoff

This figure shows the co-authorship network connecting the top 25 collaborators of James L. Weemhoff. A scholar is included among the top collaborators of James L. Weemhoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James L. Weemhoff. James L. Weemhoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Jiangting, Anna‐Liisa Nieminen, James L. Weemhoff, et al.. (2023). The mitochondrial calcium uniporter mediates mitochondrial Fe2+ uptake and hepatotoxicity after acetaminophen. Toxicology and Applied Pharmacology. 479. 116722–116722. 6 indexed citations
2.
Nguyen, Nga, Jephte Y. Akakpo, James L. Weemhoff, et al.. (2021). Impaired protein adduct removal following repeat administration of subtoxic doses of acetaminophen enhances liver injury in fed mice. Archives of Toxicology. 95(4). 1463–1473. 13 indexed citations
3.
4.
5.
Duan, Luqi, Anup Ramachandran, Jephte Y. Akakpo, et al.. (2018). Role of extracellular vesicles in release of protein adducts after acetaminophen-induced liver injury in mice and humans. Toxicology Letters. 301. 125–132. 26 indexed citations
6.
Du, Kuo, Anup Ramachandran, James L. Weemhoff, et al.. (2018). Mito-tempo protects against acute liver injury but induces limited secondary apoptosis during the late phase of acetaminophen hepatotoxicity. Archives of Toxicology. 93(1). 163–178. 51 indexed citations
7.
Maes, Michaël, Sara Crespo Yanguas, Joost Willebrords, et al.. (2017). Connexin hemichannel inhibition reduces acetaminophen-induced liver injury in mice. Toxicology Letters. 278. 30–37. 29 indexed citations
8.
Borude, Prachi, Bharat Bhushan, Hemantkumar Chavan, et al.. (2017). P53 Regulates Progression of Injury and Liver Regeneration After Acetaminophen Overdose. The FASEB Journal. 31(S1). 3 indexed citations
9.
Du, Kuo, Anup Ramachandran, James L. Weemhoff, et al.. (2016). Editor’s Highlight: Metformin Protects Against Acetaminophen Hepatotoxicity by Attenuation of Mitochondrial Oxidant Stress and Dysfunction. Toxicological Sciences. 154(2). 214–226. 63 indexed citations
10.
Maes, Michaël, Mitchell R. McGill, Tereza Cristina da Silva, et al.. (2016). Inhibition of pannexin1 channels alleviates acetaminophen-induced hepatotoxicity. Archives of Toxicology. 91(5). 2245–2261. 21 indexed citations
11.
Weemhoff, James L., Benjamin L. Woolbright, Rosalind E. Jenkins, et al.. (2016). Plasma biomarkers to study mechanisms of liver injury in patients with hypoxic hepatitis. Liver International. 37(3). 377–384. 34 indexed citations
12.
Fang, Pingping, et al.. (2016). Evidence for a “Pathogenic Triumvirate” in Congenital Hepatic Fibrosis in Autosomal Recessive Polycystic Kidney Disease. BioMed Research International. 2016. 1–10. 7 indexed citations
13.
Duan, Luqi, Benjamin L. Woolbright, Kuo Du, et al.. (2016). Differential susceptibility to acetaminophen-induced liver injury in sub-strains of C57BL/6 mice: 6N versus 6J. Food and Chemical Toxicology. 98. 107–118. 29 indexed citations
14.
McGill, Mitchell R., Kuo Du, James L. Weemhoff, & Hartmut Jaeschke. (2015). Critical review of resveratrol in xenobiotic-induced hepatotoxicity. Food and Chemical Toxicology. 86. 309–318. 27 indexed citations
15.
Yang, Min, Daniel J. Antoine, James L. Weemhoff, et al.. (2014). Biomarkers distinguish apoptotic and necrotic cell death during hepatic ischemia/reperfusion injury in mice. Liver Transplantation. 20(11). 1372–1382. 73 indexed citations
16.
Kumar, Santosh, Mengyao Jin, & James L. Weemhoff. (2012). Cytochrome P450-Mediated Phytoremediation using Transgenic Plants: A Need for Engineered Cytochrome P450 Enzymes. Journal of Petroleum & Environmental Biotechnology. 3(5). 24 indexed citations
17.
Silverstein, Peter S., Ankit Shah, James L. Weemhoff, et al.. (2012). HIV-1 gp120 and Drugs of Abuse: Interactions in the Central Nervous System. Current HIV Research. 10(5). 369–383. 53 indexed citations
18.
Bekaii‐Saab, Tanios, Michael Perloff, James L. Weemhoff, David J. Greenblatt, & Lisa L. von Moltke. (2004). Interactions of tamoxifen, N‐desmethyltamoxifen and 4‐hydroxytamoxifen with P‐glycoprotein and CYP3A. Biopharmaceutics & Drug Disposition. 25(7). 283–289. 24 indexed citations
19.
Moltke, Lisa L. von, James L. Weemhoff, Erdal Bedi̇r, et al.. (2004). Inhibition of human cytochromes P450 by components of Ginkgo biloba. Journal of Pharmacy and Pharmacology. 56(8). 1039–1044. 134 indexed citations
20.
Moltke, Lisa L. von, James L. Weemhoff, Michael Perloff, et al.. (2002). Effect of zolpidem on human Cytochrome P450 activity, and on transport mediated by P‐glycoprotein. Biopharmaceutics & Drug Disposition. 23(9). 361–367. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eduardo Fernández‐Martínez Breakdown of academic impact, for papers by M. R. Slaughter Breakdown of academic impact, for papers by Hamid Amouzadeh Breakdown of academic impact, for papers by G Pisani Breakdown of academic impact, for papers by Juhui Zhao Breakdown of academic impact, for papers by Ka Wu Breakdown of academic impact, for papers by Michael Atef Fawzy Breakdown of academic impact, for papers by Guangyao Zhou Breakdown of academic impact, for papers by Marı́a Teresa Ronco
Rankless by CCL
2026